MedPath

Evaluation of Pain Regression in Patients With Myofascial Facial Pain Using Dextrose, Local Anaesthesia and Saline.

Not Applicable
Conditions
Myofascial Pain Syndrome
Interventions
Other: Saline
Other: Local Anaesthesia
Other: Dextrose Prolotherapy
Registration Number
NCT03161210
Lead Sponsor
Cairo University
Brief Summary

The aim of this study is to compare the treatment effects of dextrose prolotherapy, saline, and mepivacaine for deactivating myofascial trigger points within the jaw muscles.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
    1. Presence of active myofacial pains in jaw muscles, previously identified by manual palpation.
  1. Age ≥ 18 years. 3. Willingness to follow instructions
Read More
Exclusion Criteria
    1. Therapeutic intervention for myofascial pain within the past month before the study, such as using of medications for pain control or wearing of occlusal splint.

    2. Clinical conditions such as pregnancy. 3. Medical problems that may interfere with the procedures such as bleeding disorders, trigeminal neuralgia.

    3. Recent facial or neck trauma; medication or adjunctive treatment (eg, physiotherapy) that could not be stopped during the study; or allergy to local anesthetic solutions.

    4. Cognitive impairment or exhibited inadequate cooperation.

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SalineSaline-
Local AnaestheticLocal Anaesthesia-
Dextrose ProlotherapyDextrose Prolotherapy-
Primary Outcome Measures
NameTimeMethod
Patients' subjective pain experienceone year

Pressure pain threshold (PPT): An algometer will be used to assess PPT. The algometer consists of a 1 cm2 rubber tipped plunger mounted on a force transducer. The pressure will be applied over the examined trigger point. The participants will be instructed to point when the sensation changed from pressure to pain. The mean of three trials will be calculated and used for analysis.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath